Full history for every metric is available with a Kvantra account

Stock profile

Probiotec Limited (PBP.AX)

Country: AustraliaSector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: ASX

Delisted · last close 19 Jun 2024

Current price
2.98 AUD0.00%
Last close 19 Jun 2024
Benchmarks

Key financial summary

Financials in AUD
201820192020202120222023TTM
Total revenueAUD m7673107121182214221
Operating profitAUD m2119
Net profitAUD m444514119
EPS reportedAUD0.130.10
Operating cashflow per shareAUD0.210.21
Capex per shareAUD0.120.12
FCF per shareAUD0.090.09
Free cash flowAUD m75
Net debtAUD m7439
Book value equityAUD m8788
Book value per shareAUD1.051.05
Number of sharesm83.0283.87
DPS (TTM paid)AUD0.110.11

Financial summary

Financials in AUD
201820192020202120222023TTM
Value
P/E TTMx21.54-
P/B LTMx2.612.74
P/S LTMx1.061.10
P/FCF LTMx32.4250.39
EV/EBITDA LTMx8.528.12
EV/Sales LTMx1.411.27
Earnings Yield LTM%4.64%4.55%
FCF Yield%3.08%1.98%
Quality
ROE%12.64%13.26%
ROIC%7.55%7.55%
Operating margin%9.69%9.69%
Gross margin%28.78%28.78%
FCF/Sales%3.28%3.28%
Growth and momentum
EPS Growth YoY%-23.53%-43.25%
Sales Growth YoY%+17.39%+8.47%
Net Income Growth YoY%-19.61%-41.01%
FCF Growth%-44.22%-49.51%
Operating Profit Growth%+5.60%-9.66%
Dividend and capital structure
Dividend Yield%2.32%3.61%
Dividend Growth%+65.38%-
Payout Ratio%47.98%47.98%
FCF/Debtx0.080.06
Net Debt/EBITDAx2.092.09
EBIT/Net interestx3.593.59
Net debt/market cap%32.43%15.98%
Net debt/Equityx0.850.44
Gross debt/equityx1.010.97

Company overview

Established in 1996 and based in Laverton North, Australia, Probiotec Limited is involved in the creation, production, packaging, and distribution of pharmaceuticals, consumer healthcare products, and fast-moving consumer goods both domestically and internationally. The company delivers extensive contract manufacturing solutions, covering the production of various formats including solid dose tablets, capsules, liquids, creams, gels, ointments, suspensions, and powders, alongside services like tablet coating, blister packing, and spray manufacturing. Furthermore, Probiotec offers analytical and stability testing, assists with new product formulation and trials, conducts continuous research and development, and provides a wide array of packaging options for human and animal nutrition items. It also manufactures and exports a selection of nutraceuticals and key functional ingredient raw materials.

WebsiteN/A
IndustryDrug Manufacturers - Specialty & Generic
CountryAustralia
Trades inAUD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 19 Jun 2024

Probiotec Limited (PBP.AX)

PBP.AX · ASX · Healthcare
2.98 AUD0.00%
Benchmarks
Financialsin AUD
20222023TTM
About

Established in 1996 and based in Laverton North, Australia, Probiotec Limited is involved in the creation, production, packaging, and distribution of pharmaceuticals, consumer healthcare products, and fast-moving consumer goods both domestically and internationally. The company delivers extensive contract manufacturing solutions, covering the production of various formats including solid dose tablets, capsules, liquids, creams, gels, ointments, suspensions, and powders, alongside services like tablet coating, blister packing, and spray manufacturing. Furthermore, Probiotec offers analytical and stability testing, assists with new product formulation and trials, conducts continuous research and development, and provides a wide array of packaging options for human and animal nutrition items. It also manufactures and exports a selection of nutraceuticals and key functional ingredient raw materials.

IndustryDrug Manufacturers - Specialty & Generic
CountryAustralia
Trades inAUD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free